Human aldehyde dehydrogenases:: Potential pathological, pharmacological, and toxicological impact

被引:213
作者
Sládek, NE [1 ]
机构
[1] Univ Minnesota, Sch Med, Dept Pharmacol, Minneapolis, MN 55455 USA
关键词
aldehyde dehydrogenases; xenobiotic metabolism; in-born errors of metabolism;
D O I
10.1002/jbt.10057
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Aldehyde dehydrogenases catalyze the pyridine nucleotide-dependent oxidation of aldehydes to acids. Seventeen enzymes are currently viewed as belonging to the human aldehyde dehydrogenase superfamily. Summarized herein, insofar as the information is available, are the structural composition, physical properties, tissue distribution, subcellular location, substrate specificity, and cofactor preference of each member of this superfamily. Also summarized are the chromosomal locations and organization of the genes that encode these enzymes and the biological consequences when enzyme activity is lost or substantially diminished. Broadly, aldehyde dehydrogenases can be categorized as critical for normal development and/or physiological homeostasis (1) even when the organism is in a friendly environment or (2) only when the organism finds itself in a hostile environment. The primary, if not sole, evolved raison d'etre of first category aldehyde dehydrogenases appears to be to catalyze the biotransformation of a single endobiotic for which they are relatively specific and of which the resultant metabolite is essential to the organism. Most of the human aldehyde dehydrogenases for which the relevant information is available fall into this category. Second category aldehyde dehydrogenases are relatively substrate nonspecific and their evolved raison d'etre seems to be to protect the organism from potentially harmful xenobiotics, specifically aldehydes or xenobiotics that give rise to aldehydes, by catalyzing their detoxification. Thus, the lack of a fully functional first category aldehyde dehydrogenase results in a gross pathological phenotype in the absence of any insult, whereas the lack of a functional second category aldehyde dehydrogenase is ordinarily of no consequence with respect to gross phenotype, but is of consequence in that regard when the organism is subjected to a relevant insult. (C) 2003 Wiley Periodicals, Inc.
引用
收藏
页码:7 / 23
页数:17
相关论文
共 213 条
[1]  
Agarwal D P, 1989, Prog Clin Biol Res, V290, P119
[2]  
AGARWAL DP, 1987, ISOZYMES-CURR T BIOL, V16, P21
[3]   ALDEHYDE DEHYDROGENASE FROM HUMAN-ERYTHROCYTES - STRUCTURAL RELATIONSHIP TO THE LIVER CYTOSOLIC ISOZYME [J].
AGARWAL, DP ;
COHN, P ;
GOEDDE, HW ;
HEMPEL, J .
ENZYME, 1989, 42 (01) :47-52
[4]  
AKIYAMA Y, 2000, P AM ASSOC CANC RES, V41, P598
[5]  
AMBROZIAK W, 1991, J BIOL CHEM, V266, P13011
[6]   Metabolism of retinaldehyde and other aldehydes in soluble extracts of human liver and kidney [J].
Ambroziak, W ;
Izaguirre, G ;
Pietruszko, R .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (47) :33366-33373
[7]   ALDEHYDE DEHYDROGENASE (EC 1.2.1.3) - COMPARISON OF SUBCELLULAR-LOCALIZATION OF THE 3RD ISOZYME THAT DEHYDROGENATES GAMMA-AMINOBUTYRALDEHYDE IN RAT, GUINEA-PIG AND HUMAN LIVER [J].
AMBROZIAK, W ;
KURYS, G ;
PIETRUSZKO, R .
COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY B-BIOCHEMISTRY & MOLECULAR BIOLOGY, 1991, 100 (02) :321-327
[8]  
AMBROZIAK W, 1993, ADV EXP MED BIOL, V328, P5
[9]  
[Anonymous], 1985, IARC Monogr Eval Carcinog Risk Chem Hum, V36, P101
[10]  
[Anonymous], 1999, IARC Monogr Eval Carcinog Risks Hum, V71 Pt 2, P319